References
- FolkmanJTumor angiogenesis: therapeutic implicationsN Engl J Med197128521118211864938153
- BrooksPCClarkRAChereshDARequirement of vascular integrin αvβ3 for angiogenesisScience199426451585695717512751
- MaxRGerritsenRRNooijenPTImmunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomasInt J Cancer19977133203249139861
- LiuZWangFChenXIntegrin αvβ3-targeted cancer therapyDrug Dev Res200869632933920628538
- LiuZWangFDevelopment of RGD-based radiotracer for tumor imaging and therapy: translating from bench to besidesCurr Mol Med201313101487150524206140
- LiYLiuZDongCNoninvasive detection of human-induced pluripotent stem cell (hiPSC)-derived teratoma with an integrin-targeting agent (99m)Tc-3PRGD2Mol Imaging Biol2013151586722707047
- AlamISWitneyTHTomasiGRadiolabeled RGD tracer kinetics annotates differential αvβ3 integrin expression linked to cell intrinsic and vessel expressionsMol Imaging Biol201416455856624310722
- ChoiYKimELeeYHanMHKangICSite-specific inhibition of integrin αvβ3-vitronectin association by a Ser-Asp-Val sequence through an Arg-Gly-Asp-binding site of the integrinProteomics2010101728019882657
- LiuYYangYZhangCA concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probesInt J Nanomedicine201381083109323515638
- ZanJHeXLongWLiuPInsights into binding modes of tumstatin peptide T7 with the active site of αvβ3 integrinMol Simulat201238498508
- MaeshimaYColoradoPCTorreADistinct antitumor properties of a type IV collagen domain derived from basement membraneJ Biol Chem200027528213402134810766752
- MaeshimaYColoradoPCKalluriRTwo RGD-independent alpha v beta 3 integrin binding sites on tumstatin regulate distinct anti-tumor propertiesJ Biol Chem200027531237452375010837460
- PetitclercEBoutaudAPrestaykoANew functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivoJ Biol Chem2000275118051806110713126
- MaeshimaYYerramallaULDhanabalMExtracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesisJ Biol Chem200127634319593196811399763
- EikesdalHPSugimotoHBirraneGIdentification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activityProc Natl Acad Sci USA200810539150401504518818312
- MaguireJJKucREDavenportAPRadio ligand binding assays and their analysisReceptor Binding TechniquesNew YorkHumana Press20051819101102121122203204
- DavenportAPRusselFDRadio ligand binding assays: theory and practiceMatherSJCurrent Directions in Radiopharmaceutical Research and DevelopmentAmsterdamSpringer Netherlands1996169179
- GraftonKTMoirLMBlackJLLF-15 and T7, synthetic peptides derived from tumstatin, attenuate aspects of airway remodelling in a murine model of chronic OVA-induced allergic airway diseasePLoS One201491e8565524454912
- TakagiJPetreBMWalzTSpringerTAGlobal conformational rearrangements in integrin extracellular domains in outside-in and inside-out signalingCell2002110559961112230977
- ZhangXXiongZWuYQuantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2J Nucl Med200647111312116391195
- GaertnerFCKesslerHWesterHJSchwaigerMBeerAJRadiolabelled RGD peptides for imaging and therapyEur J Nucl Med Mol Imaging201239Suppl 1S126S13822388629
- SchotteliusMLauferBKesslerHWesterHJLigands for mapping alphavbeta3-integrin expression in vivoAcc Chem Res200942796998019489579
- LiuZWangFDevelopment of RGD-based radiotracers for tumor imaging and therapy: translating from bench to bedsideCurr Mol Med201313101487150524206140
- HaubnerRWesterHJBurkhartFGlycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokineticsJ Nucl Med200142232633611216533
- BattleMRGoggiJLAllenLBarnettJMorrisonMSMonitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agentJ Nucl Med201152342443021321268
- TerrySYAbirajKFrielinkCImaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenograftsJ Nucl Med201455228128624408894
- JiSZhouYVoorbachMJMonitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2J Pharmacol Exp Ther2013346225125823750021